Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Oncology Institute (TOI) Equity Ratio (2020 - 2025)

Oncology Institute (TOI) has disclosed Equity Ratio for 6 consecutive years, with 0.08 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Equity Ratio fell 186.82% year-over-year to 0.08, compared with a TTM value of 0.08 through Sep 2025, down 186.82%, and an annual FY2024 reading of 0.02, down 92.38% over the prior year.
  • Equity Ratio was 0.08 for Q3 2025 at Oncology Institute, down from 0.06 in the prior quarter.
  • Across five years, Equity Ratio topped out at 0.65 in Q2 2022 and bottomed at 0.08 in Q3 2025.
  • Average Equity Ratio over 5 years is 0.27, with a median of 0.22 recorded in 2021.
  • The sharpest move saw Equity Ratio skyrocketed 387.22% in 2021, then tumbled 186.82% in 2025.
  • Year by year, Equity Ratio stood at 0.51 in 2021, then fell by 8.06% to 0.47 in 2022, then tumbled by 42.1% to 0.27 in 2023, then tumbled by 92.38% to 0.02 in 2024, then tumbled by 461.01% to 0.08 in 2025.
  • Business Quant data shows Equity Ratio for TOI at 0.08 in Q3 2025, 0.06 in Q2 2025, and 0.03 in Q1 2025.